PhiChem Corporation
300398.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CN¥2,917,539 | CN¥2,728,683 | CN¥2,906,806 | CN¥2,627,104 |
| % Growth | 6.9% | -6.1% | 10.6% | – |
| Cost of Goods Sold | CN¥1,912,683 | CN¥1,792,283 | CN¥1,764,827 | CN¥1,582,197 |
| Gross Profit | CN¥1,004,856 | CN¥936,401 | CN¥1,141,978 | CN¥1,044,908 |
| % Margin | 34.4% | 34.3% | 39.3% | 39.8% |
| R&D Expenses | CN¥181,646 | CN¥189,235 | CN¥183,693 | CN¥192,743 |
| G&A Expenses | CN¥267,897 | CN¥302,759 | CN¥245,839 | CN¥209,414 |
| SG&A Expenses | CN¥429,702 | CN¥438,347 | CN¥395,768 | CN¥337,223 |
| Sales & Mktg Exp. | CN¥161,805 | CN¥135,588 | CN¥149,929 | CN¥127,809 |
| Other Operating Expenses | CN¥85,145 | CN¥157,442 | CN¥67,521 | CN¥36,654 |
| Operating Expenses | CN¥696,494 | CN¥785,024 | CN¥646,982 | CN¥566,620 |
| Operating Income | CN¥308,363 | CN¥151,377 | CN¥494,996 | CN¥478,287 |
| % Margin | 10.6% | 5.5% | 17% | 18.2% |
| Other Income/Exp. Net | -CN¥3,437 | -CN¥135 | -CN¥1,886 | -CN¥3,873 |
| Pre-Tax Income | CN¥304,926 | CN¥151,242 | CN¥493,111 | CN¥474,415 |
| Tax Expense | CN¥32,557 | CN¥15,431 | CN¥49,573 | CN¥73,450 |
| Net Income | CN¥246,527 | CN¥112,353 | CN¥434,572 | CN¥385,866 |
| % Margin | 8.4% | 4.1% | 15% | 14.7% |
| EPS | 0.47 | 0.21 | 0.84 | 0.756 |
| % Growth | 123.8% | -75% | 11.1% | – |
| EPS Diluted | 0.47 | 0.21 | 0.84 | 0.756 |
| Weighted Avg Shares Out | 524,525 | 535,016 | 517,348 | 510,329 |
| Weighted Avg Shares Out Dil | 524,525 | 535,016 | 517,348 | 510,329 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥18,019 | CN¥19,644 | CN¥13,371 | CN¥15,280 |
| Interest Expense | CN¥54,148 | CN¥67,683 | CN¥67,976 | CN¥77,737 |
| Depreciation & Amortization | CN¥184,301 | CN¥177,542 | CN¥145,606 | CN¥121,139 |
| EBITDA | CN¥531,660 | CN¥458,878 | CN¥685,875 | CN¥604,678 |
| % Margin | 18.2% | 16.8% | 23.6% | 23% |